Blood sugar and rheumatoid arthritis activity in people with diabetes
Part of Bones, joints & muscles, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study looks at how well blood sugar is controlled in people who have both type 2 diabetes and rheumatoid arthritis. The goal is to see if better blood sugar control can help reduce rheumatoid arthritis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes (not type 1 or gestational).
- You have been diagnosed with rheumatoid arthritis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.
This study tests whether two diabetes medications, dapagliflozin and empagliflozin, can help reduce rheumatoid arthritis symptoms when added to your current methotrexate treatment. It may offer a new option for people whose arthritis is still active despite methotrexate.
This study is testing a new blood test that may help diagnose rheumatoid arthritis (RA) by detecting a specific antibody. If it works, it could lead to earlier and more accurate diagnosis.
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
This study compares two types of medication for rheumatoid arthritis to see which one might be better. It looks at how these drugs affect your daily life and physical abilities. If you have RA and are on one of these drugs, this study could help you understand your treatment better.
This study uses a special skin scanner to measure sugar-related damage in the body, which may be linked to inflammation. It compares people with rheumatic conditions to healthy volunteers to see if the scanner can help track or predict disease.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.